World Non-small Cell Lung Cancer Market Research Report 2025 (covering USA, Europe, China, Japan, India, South East Asia and etc)
Mar, 2020
|
Report ID: 118875
|
109
|
Pharmaceuticals and Healthcare
Summary
Non-small Cell Lung Cancer market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Non-small Cell Lung Cancer
Market: Product Segment Analysis
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
Global Non-small Cell Lung Cancer
Market: Application Segment Analysis
Global Non-small Cell Lung Cancer
Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi
ZIOPHARM Oncology
Alchemia
Amgen
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Menarini
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Non-small Cell Lung Cancer market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Non-small Cell Lung Cancer
Market: Product Segment Analysis
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
Global Non-small Cell Lung Cancer
Market: Application Segment Analysis
Global Non-small Cell Lung Cancer
Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi
ZIOPHARM Oncology
Alchemia
Amgen
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Menarini
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Content
Chapter 1 About the Non-small Cell Lung Cancer Industry
1.1 Industry Definition and Types
1.1.1 Surgery
1.1.2 Radiofrequency ablation (RFA)
1.1.3 Radiation therapy
1.1.1.4 Chemotherapy
1.1.1.5 Targeted therapies
1.1.1.6 Immunotherapy
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance
Chapter 2 World Market Competition Landscape
2.1 Non-small Cell Lung Cancer Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.3 China
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.4 India
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.2 World Non-small Cell Lung Cancer Market by Types
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
2.3 World Non-small Cell Lung Cancer Market by Applications
2.4 World Non-small Cell Lung Cancer Market Analysis
2.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2015-2019
2.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2015-2019
2.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2015-2019
Chapter 3 World Non-small Cell Lung Cancer Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2019, Through 2025
3.4 Major Revenue (M USD) Market share By Regions in 2019, Through 2025
Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2015-2019
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis
Chapter 5 Company Profiles
5.1 Bristol-Myers Squibb
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 GlaxoSmithKline
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Sanofi
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 ZIOPHARM Oncology
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Alchemia
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Amgen
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Apotex
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 BioMarin Pharmaceutical
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 CellAct Pharma
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Menarini
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Cerulean Pharma
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Cipla
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 Cornerstone Pharmaceuticals
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
5.14 Curis
5.14.1 Company Details (Foundation Year, Employee Strength and etc)
5.14.2 Product Information (Picture, Specifications and Applications)
5.14.3 Revenue (M USD), Price and Operating Profits
5.15 CytRx
5.15.1 Company Details (Foundation Year, Employee Strength and etc)
5.15.2 Product Information (Picture, Specifications and Applications)
5.15.3 Revenue (M USD), Price and Operating Profits
5.16 Eli Lilly
5.16.1 Company Details (Foundation Year, Employee Strength and etc)
5.16.2 Product Information (Picture, Specifications and Applications)
5.16.3 Revenue (M USD), Price and Operating Profits
5.17 Exelixis
5.17.1 Company Details (Foundation Year, Employee Strength and etc)
5.17.2 Product Information (Picture, Specifications and Applications)
5.17.3 Revenue (M USD), Price and Operating Profits
5.18 Fresenius Kabi
5.18.1 Company Details (Foundation Year, Employee Strength and etc)
5.18.2 Product Information (Picture, Specifications and Applications)
5.18.3 Revenue (M USD), Price and Operating Profits
5.19 Genentech
5.19.1 Company Details (Foundation Year, Employee Strength and etc)
5.19.2 Product Information (Picture, Specifications and Applications)
5.19.3 Revenue (M USD), Price and Operating Profits
5.20 Hikma Pharmaceuticals
5.20.1 Company Details (Foundation Year, Employee Strength and etc)
5.20.2 Product Information (Picture, Specifications and Applications)
5.20.3 Revenue (M USD), Price and Operating Profits
5.21 Hospira
5.21.1 Company Details (Foundation Year, Employee Strength and etc)
5.21.2 Product Information (Picture, Specifications and Applications)
5.21.3 Revenue (M USD), Price and Operating Profits
5.22 Intas Pharmaceuticals
5.22.1 Company Details (Foundation Year, Employee Strength and etc)
5.22.2 Product Information (Picture, Specifications and Applications)
5.22.3 Revenue (M USD), Price and Operating Profits
5.23 Karyopharm Therapeutics
5.23.1 Company Details (Foundation Year, Employee Strength and etc)
5.23.2 Product Information (Picture, Specifications and Applications)
5.23.3 Revenue (M USD), Price and Operating Profits
5.24 Kyowa Hakko Kirin
5.24.1 Company Details (Foundation Year, Employee Strength and etc)
5.24.2 Product Information (Picture, Specifications and Applications)
5.24.3 Revenue (M USD), Price and Operating Profits
5.25 Ligand Pharmaceuticals
5.25.1 Company Details (Foundation Year, Employee Strength and etc)
5.25.2 Product Information (Picture, Specifications and Applications)
5.25.3 Revenue (M USD), Price and Operating Profits
Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry
Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions
Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India
Chapter 9 World Non-small Cell Lung Cancer Market Forecast through 2025
9.1 World Non-small Cell Lung Cancer Demand by Regions Forecast through 2025
9.2 World Non-small Cell Lung Cancer Price(by Regions, Types, Applications)Analysis Forecast through 2025
9.3 World Non-small Cell Lung Cancer Revenue (M USD)(by Regions, Types, Applications) Forecast through 2025
9.4 World Non-small Cell Lung Cancer Market Analysis
9.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2015-2019
9.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2015-2019
9.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2015-2019
Chapter 10 Key success factors and Market Overview
Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Major Production Market share by Players 2019
Table Major Revenue (M USD) Market share by Players 2019
Table Production Market share by Major Regions in 2015-2019
Table Production Market share by Major Regions in 2019-2025
Table Revenue (M USD) Market share by Regions in 2015-2019
Table Revenue (M USD) Market share by Regions in 2019-2025
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2015-2019
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Bristol-Myers Squibb Information List
Figure Non-small Cell Lung CancerNon-small Cell Lung Cancer Picture, Specifications and Applications of Bristol-Myers Squibb
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bristol-Myers Squibb 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Bristol-Myers Squibb 2019-2019
Table GlaxoSmithKline Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of GlaxoSmithKline
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GlaxoSmithKline 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of GlaxoSmithKline 2019-2019
Table Sanofi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Sanofi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Sanofi 2019-2019
Table ZIOPHARM Oncology Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of ZIOPHARM Oncology
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of ZIOPHARM Oncology 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of ZIOPHARM Oncology 2019-2019
Table Alchemia Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Alchemia
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Alchemia 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Alchemia 2019-2019
Table Amgen Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Amgen
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Amgen 2019-2019
Table Apotex Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Apotex
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Apotex 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Apotex 2019-2019
Table BioMarin Pharmaceutical Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of BioMarin Pharmaceutical
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of BioMarin Pharmaceutical 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of BioMarin Pharmaceutical 2019-2019
Table CellAct Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CellAct Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CellAct Pharma 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CellAct Pharma 2019-2019
Table Menarini Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Menarini
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Menarini 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Menarini 2019-2019
Table Cerulean Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cerulean Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cerulean Pharma 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cerulean Pharma 2019-2019
Table Cipla Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cipla
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cipla 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cipla 2019-2019
Table Cornerstone Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cornerstone Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cornerstone Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cornerstone Pharmaceuticals 2019-2019
Table Curis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Curis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Curis 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Curis 2019-2019
Table CytRx Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CytRx
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CytRx 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CytRx 2019-2019
Table Eli Lilly Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Eli Lilly
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eli Lilly 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Eli Lilly 2019-2019
Table Exelixis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Exelixis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Exelixis 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Exelixis 2019-2019
Table Fresenius Kabi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Fresenius Kabi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Fresenius Kabi 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Fresenius Kabi 2019-2019
Table Genentech Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Genentech
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Genentech 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Genentech 2019-2019
Table Hikma Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hikma Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hikma Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hikma Pharmaceuticals 2019-2019
Table Hospira Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hospira
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hospira 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hospira 2019-2019
Table Intas Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Intas Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Intas Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Intas Pharmaceuticals 2019-2019
Table Karyopharm Therapeutics Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Karyopharm Therapeutics
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Karyopharm Therapeutics 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Karyopharm Therapeutics 2019-2019
Table Kyowa Hakko Kirin Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Kyowa Hakko Kirin
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Kyowa Hakko Kirin 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Kyowa Hakko Kirin 2019-2019
Table Ligand Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Ligand Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Ligand Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Ligand Pharmaceuticals 2019-2019
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Types Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Applications Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Types Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Applications Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Chapter 1 About the Non-small Cell Lung Cancer Industry
1.1 Industry Definition and Types
1.1.1 Surgery
1.1.2 Radiofrequency ablation (RFA)
1.1.3 Radiation therapy
1.1.1.4 Chemotherapy
1.1.1.5 Targeted therapies
1.1.1.6 Immunotherapy
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance
Chapter 2 World Market Competition Landscape
2.1 Non-small Cell Lung Cancer Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.3 China
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.4 India
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2015-2025
Sales and Growth Rate 2015-2025
Major Players Revenue (M USD) in 2019
2.2 World Non-small Cell Lung Cancer Market by Types
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
2.3 World Non-small Cell Lung Cancer Market by Applications
2.4 World Non-small Cell Lung Cancer Market Analysis
2.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2015-2019
2.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2015-2019
2.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2015-2019
Chapter 3 World Non-small Cell Lung Cancer Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2019, Through 2025
3.4 Major Revenue (M USD) Market share By Regions in 2019, Through 2025
Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2015-2019
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis
Chapter 5 Company Profiles
5.1 Bristol-Myers Squibb
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 GlaxoSmithKline
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Sanofi
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 ZIOPHARM Oncology
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Alchemia
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Amgen
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Apotex
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 BioMarin Pharmaceutical
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 CellAct Pharma
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Menarini
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Cerulean Pharma
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Cipla
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 Cornerstone Pharmaceuticals
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
5.14 Curis
5.14.1 Company Details (Foundation Year, Employee Strength and etc)
5.14.2 Product Information (Picture, Specifications and Applications)
5.14.3 Revenue (M USD), Price and Operating Profits
5.15 CytRx
5.15.1 Company Details (Foundation Year, Employee Strength and etc)
5.15.2 Product Information (Picture, Specifications and Applications)
5.15.3 Revenue (M USD), Price and Operating Profits
5.16 Eli Lilly
5.16.1 Company Details (Foundation Year, Employee Strength and etc)
5.16.2 Product Information (Picture, Specifications and Applications)
5.16.3 Revenue (M USD), Price and Operating Profits
5.17 Exelixis
5.17.1 Company Details (Foundation Year, Employee Strength and etc)
5.17.2 Product Information (Picture, Specifications and Applications)
5.17.3 Revenue (M USD), Price and Operating Profits
5.18 Fresenius Kabi
5.18.1 Company Details (Foundation Year, Employee Strength and etc)
5.18.2 Product Information (Picture, Specifications and Applications)
5.18.3 Revenue (M USD), Price and Operating Profits
5.19 Genentech
5.19.1 Company Details (Foundation Year, Employee Strength and etc)
5.19.2 Product Information (Picture, Specifications and Applications)
5.19.3 Revenue (M USD), Price and Operating Profits
5.20 Hikma Pharmaceuticals
5.20.1 Company Details (Foundation Year, Employee Strength and etc)
5.20.2 Product Information (Picture, Specifications and Applications)
5.20.3 Revenue (M USD), Price and Operating Profits
5.21 Hospira
5.21.1 Company Details (Foundation Year, Employee Strength and etc)
5.21.2 Product Information (Picture, Specifications and Applications)
5.21.3 Revenue (M USD), Price and Operating Profits
5.22 Intas Pharmaceuticals
5.22.1 Company Details (Foundation Year, Employee Strength and etc)
5.22.2 Product Information (Picture, Specifications and Applications)
5.22.3 Revenue (M USD), Price and Operating Profits
5.23 Karyopharm Therapeutics
5.23.1 Company Details (Foundation Year, Employee Strength and etc)
5.23.2 Product Information (Picture, Specifications and Applications)
5.23.3 Revenue (M USD), Price and Operating Profits
5.24 Kyowa Hakko Kirin
5.24.1 Company Details (Foundation Year, Employee Strength and etc)
5.24.2 Product Information (Picture, Specifications and Applications)
5.24.3 Revenue (M USD), Price and Operating Profits
5.25 Ligand Pharmaceuticals
5.25.1 Company Details (Foundation Year, Employee Strength and etc)
5.25.2 Product Information (Picture, Specifications and Applications)
5.25.3 Revenue (M USD), Price and Operating Profits
Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry
Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions
Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India
Chapter 9 World Non-small Cell Lung Cancer Market Forecast through 2025
9.1 World Non-small Cell Lung Cancer Demand by Regions Forecast through 2025
9.2 World Non-small Cell Lung Cancer Price(by Regions, Types, Applications)Analysis Forecast through 2025
9.3 World Non-small Cell Lung Cancer Revenue (M USD)(by Regions, Types, Applications) Forecast through 2025
9.4 World Non-small Cell Lung Cancer Market Analysis
9.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2015-2019
9.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2015-2019
9.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2015-2019
Chapter 10 Key success factors and Market Overview
Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Market Revenue (M USD) and Growth Rate 2015-2025
Table Major Players Revenue (M USD) in 2019
Table Major Production Market share by Players 2019
Table Major Revenue (M USD) Market share by Players 2019
Table Production Market share by Major Regions in 2015-2019
Table Production Market share by Major Regions in 2019-2025
Table Revenue (M USD) Market share by Regions in 2015-2019
Table Revenue (M USD) Market share by Regions in 2019-2025
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2015-2019
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Bristol-Myers Squibb Information List
Figure Non-small Cell Lung CancerNon-small Cell Lung Cancer Picture, Specifications and Applications of Bristol-Myers Squibb
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bristol-Myers Squibb 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Bristol-Myers Squibb 2019-2019
Table GlaxoSmithKline Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of GlaxoSmithKline
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GlaxoSmithKline 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of GlaxoSmithKline 2019-2019
Table Sanofi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Sanofi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Sanofi 2019-2019
Table ZIOPHARM Oncology Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of ZIOPHARM Oncology
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of ZIOPHARM Oncology 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of ZIOPHARM Oncology 2019-2019
Table Alchemia Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Alchemia
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Alchemia 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Alchemia 2019-2019
Table Amgen Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Amgen
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Amgen 2019-2019
Table Apotex Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Apotex
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Apotex 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Apotex 2019-2019
Table BioMarin Pharmaceutical Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of BioMarin Pharmaceutical
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of BioMarin Pharmaceutical 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of BioMarin Pharmaceutical 2019-2019
Table CellAct Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CellAct Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CellAct Pharma 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CellAct Pharma 2019-2019
Table Menarini Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Menarini
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Menarini 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Menarini 2019-2019
Table Cerulean Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cerulean Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cerulean Pharma 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cerulean Pharma 2019-2019
Table Cipla Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cipla
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cipla 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cipla 2019-2019
Table Cornerstone Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cornerstone Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cornerstone Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cornerstone Pharmaceuticals 2019-2019
Table Curis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Curis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Curis 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Curis 2019-2019
Table CytRx Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CytRx
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CytRx 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CytRx 2019-2019
Table Eli Lilly Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Eli Lilly
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eli Lilly 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Eli Lilly 2019-2019
Table Exelixis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Exelixis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Exelixis 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Exelixis 2019-2019
Table Fresenius Kabi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Fresenius Kabi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Fresenius Kabi 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Fresenius Kabi 2019-2019
Table Genentech Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Genentech
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Genentech 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Genentech 2019-2019
Table Hikma Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hikma Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hikma Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hikma Pharmaceuticals 2019-2019
Table Hospira Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hospira
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hospira 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hospira 2019-2019
Table Intas Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Intas Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Intas Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Intas Pharmaceuticals 2019-2019
Table Karyopharm Therapeutics Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Karyopharm Therapeutics
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Karyopharm Therapeutics 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Karyopharm Therapeutics 2019-2019
Table Kyowa Hakko Kirin Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Kyowa Hakko Kirin
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Kyowa Hakko Kirin 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Kyowa Hakko Kirin 2019-2019
Table Ligand Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Ligand Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Ligand Pharmaceuticals 2019-2019
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Ligand Pharmaceuticals 2019-2019
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Types Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Price by Applications Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Regions Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Types Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
Table World Revenue (M USD) by Applications Forecast Analysis of Non-small Cell Lung Cancer (2019-2025)
